Ropidoxuridine
Ropidoxuridine (IPdR) is a novel orally available, halogenated thymidine analog and is a potential radiosensitizer for use in human tumors.
Product Specifications
CAS Number
[93265-81-7]
Product Name Alternative
IPdR
UNSPSC
12352005
Hazard Statement
H302+H312+H332, H315, H319, H341, H361
Target
HSV
Type
Reference compound
Related Pathways
Anti-infection
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/Ropidoxuridine.html
Purity
99.59
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
O=C1N=CC(I)=CN1[C@H]2C[C@H](O)[C@@H](CO)O2
Molecular Formula
C9H11IN2O4
Molecular Weight
338.10
Precautions
H302+H312+H332, H315, H319, H341, H361
References & Citations
[1]Rampurwala MM, et al. Ropidoxuridine (IPdR) potentiates alisertib (MLN8237) activity in triple-negative breast cancer. [abstract]. In: Proceedings of the Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2015 Dec 8-12; San Antonio, TX. Philadelphia (PA) : AACR; Cancer Res 2016;76 (4 Suppl) :Abstract nr P6-13-16.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
H2033-23-ML550 100 µL
Herpes Simplex Virus I, II, Glycoprotein D (HSV I, II) (MaxLight 550) discontinued
Ask
View Details 
